Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Chakravarthy AB, Zhao F, Meropol NJ, Flynn PJ, Wagner LI, Sloan J, Diasio RB, Mitchell EP, Catalano P, Giantonio BJ, Catalano RB, Haller DG, Awan RA, Mulcahy MF, O'Brien TE, Santala R, Cripps C, Weis JR, Atkins JN, Leichman CG, Petrelli NJ, Sinicrope FA, Brierley JD, Tepper JE, O'Dwyer PJ, Sigurdson ER, Hamilton SR, Cella D, Benson AB 3rd. Chakravarthy AB, et al. Among authors: mulcahy mf. Oncologist. 2020 May;25(5):e798-e807. doi: 10.1634/theoncologist.2019-0437. Epub 2019 Dec 18. Oncologist. 2020. PMID: 31852811 Free PMC article. Clinical Trial.
Bevacizumab in the treatment of colorectal cancer.
Mulcahy MF, Benson AB 3rd. Mulcahy MF, et al. Expert Opin Biol Ther. 2005 Jul;5(7):997-1005. doi: 10.1517/14712598.5.7.997. Expert Opin Biol Ther. 2005. PMID: 16018743 Review.
Bevacizumab in the treatment of colorectal cancer.
Cilley JC, Barfi K, Benson AB 3rd, Mulcahy MF. Cilley JC, et al. Among authors: mulcahy mf. Expert Opin Biol Ther. 2007 May;7(5):739-49. doi: 10.1517/14712598.7.5.739. Expert Opin Biol Ther. 2007. PMID: 17477810 Review.
Panitumumab in metastatic colorectal cancer.
Wisinski KB, Mulcahy MF, Benson AB 3rd. Wisinski KB, et al. Among authors: mulcahy mf. Clin Adv Hematol Oncol. 2007 Jan;5(1 Suppl 1):10-1. Clin Adv Hematol Oncol. 2007. PMID: 17491586 No abstract available.
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
Small W Jr, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ. Small W Jr, et al. Among authors: mulcahy mf. J Clin Oncol. 2008 Feb 20;26(6):942-7. doi: 10.1200/JCO.2007.13.9014. J Clin Oncol. 2008. PMID: 18281668 Clinical Trial.
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.
Scott LC, Yao JC, Benson AB 3rd, Thomas AL, Falk S, Mena RR, Picus J, Wright J, Mulcahy MF, Ajani JA, Evans TR. Scott LC, et al. Among authors: mulcahy mf. Cancer Chemother Pharmacol. 2009 Jan;63(2):363-70. doi: 10.1007/s00280-008-0746-2. Epub 2008 Apr 9. Cancer Chemother Pharmacol. 2009. PMID: 18398613 Clinical Trial.
208 results